Skip to content

Effects of low-dose S(+)-ketamine on chronic pain after thoracoscopic radical resection of lung cancer: a prospective randomized controlled study

Effects of low-dose S(+)-ketamine on chronic pain after thoracoscopic radical resection of lung cancer: a prospective randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042140
Enrollment
Unknown
Registered
2021-01-14
Start date
2021-02-01
Completion date
Unknown
Last updated
2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain after surgery

Interventions

Observation Group SK:Before induction of general anaesthesia, a low dose of S(+)-ketamine 0.5mg/kg was diluted with normal saline to 10ml for intravenous injection
Control Group C:Before induction of general anesthesia, 10ml normal saline should be injected intravenously

Sponsors

Drum Tower Hospital, Nanjing, Jiangsu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients selectively undergoing elective two-port video-assisted thoracoscopic surgery for unilateral pulmonary lesion 2. Male or female; aged 18-65; ASA I-III level; BMI 18 to 30 Kg/m2; 3. Join voluntarily and sign informed consent; 4. Patients who transferred to the general ward after operation.

Exclusion criteria

Exclusion criteria: 1. Patients with severe hypertension, intracranial space occupation or intracranial hypertension;recent brain injury, cerebral infarction, cerebral hemorrhage patients;patients with other systemic tumors or severe organ; dysfunction; Patients with glaucoma and hyperthyroidism; 2. Patients with mental or neurological diseases, cognitive and language dysfunction, and low level of education, unable to cooperate with the follow-up; 3. Patients with the history of chronic pain; 4. Patients with the substance abuse or dependence like analgesics, antianxiety drugs, sleeping pills; 5. Patients having a history of recovery from abnormal surgical anesthesia; 6. Patients who are allergic to the test drugs; 7. Patients undergoing thoracoscopic mediastinal, pleural and other non-pulmonary masses resection; 8. patients with clearly diagnosed recurrence or metastasis of malignant tumors after surgery.

Design outcomes

Primary

MeasureTime frame
The incidence and severity of chronic pain;

Secondary

MeasureTime frame
vital signs;Types and dosages of postoperative analgesic drugs;Incidence of postoperative acute pain and pain score;times of pressing analgesic pump,Dose and type of analgesic drugs;Drug-related adverse reactions;Postoperative complications during hospitalization and Clavien-Dindo classification;the scores of anxiety and sleep on 1d and 3d after operation;The incidence of pain, the score of pain, types and dosages of analgesics used on 30 days after operation;

Countries

China

Contacts

Public ContactRong Zhou

Drum Tower Hospital, Nanjing, Jiangsu

220193772@seu.edu.cn+86 15850689866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026